Physician profile
Derrick Railey
NPI 1891237814
$1,123.67
in general payments reported to CMS, 2019-2025
12 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $130 · 2023: $199 · 2024: $279 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $336.61 | 2021-2025 | |
| Novo Nordisk INC | $274.16 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $168.76 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.01 | 2023-2025 | Lifevest |
| Baxter Healthcare | $54.12 | 2022-2023 | Floseal |
| Pfizer INC. | $51.87 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $46.62 | 2023-2024 | |
| Melinta Therapeutics, LLC | $46.59 | 2024-2025 | Rezzayo, Kimyrsa |
| Dexcom, INC. | $45.73 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $19.04 | 2021 | |
| Glaxosmithkline, LLC. | $13.83 | 2021 | |
| Genentech USA, INC. | $10.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Railey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.